Efficacy of pretreatment of allografts with methoxypolyethylene glycol-succinimidyl-propionic acid ester in combination with an anti-OX40L monoclonal antibody in relieving graft-versus-host disease in mice

International Journal of Hematology

Volumn 92, Issue 4, 2010, Pages 609-616

  Huang, Yihong ^a   Feng, Saran ^a   Tang, Renxian ^a   Du, Bing ^a   Xu, Kailin ^a   Pan, Xiuying ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Anti OX40L monoclonal antibody; Chemical modification; Graft versus host disease; Immune tolerance; Methoxypolyethylene glycol

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MACROGOL DERIVATIVE; METHOXYPOLYETHYELENE GLYCOL SUCCINIMIDYL PROPIONIC ACID ESTER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX40L; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; GRAFT RECIPIENT; IRRADIATION; MALE; MIXED CELL CULTURE; MOUSE; MYELOABLATIVE CONDITIONING; NONHUMAN; PROTEIN BLOOD LEVEL; SPLEEN CELL; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; CYTOKINES; FEMALE; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT VS HOST DISEASE; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYETHYLENE GLYCOLS; SPLEEN; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTORS;

EID: 78549269070     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0701-y     Document Type: Article

References (27)

1. N Schmitz M Eapen MM Horowitz MJ Zhang JP Klein JD Rizzo, et al. 2006 Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for blood and marrow transplantation Blood 108 4288 4290 1:CAS:528:DC%2BD28XhtlWqsrbO 10.1182/blood-2006-05-024042 16946302 (Pubitemid 44913306)
2. M Eapen MM Horowitz JP Klein RE Champlin FR Loberiza Jr O Ringden, et al. 2004 Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry J Clin Oncol 22 4872 4880 10.1200/JCO.2004.02.189 15520055 (Pubitemid 46638610)
3. KA Newell CP Larsen 2007 Transplantation tolerance Semin Nephrol 27 487 497 1:CAS:528:DC%2BD2sXptFGqtL4%3D 10.1016/j.semnephrol.2007.03.008 17616279 (Pubitemid 47002071)
4. DP Baker EY Lin K Lin M Pellegrini RC Petter LL Chen, et al. 2006 N-terminally PEGylated human interferon-beta-1a with improved pharmacokinetic properties and in vivo efficacy in a melanoma angiogenesis model Bioconjug Chem 17 179 188 1:CAS:528:DC%2BD2MXht1KktrrM 10.1021/bc050237q 16417267 (Pubitemid 43157600)
5. SI Gundersen AF Palmer 2007 Conjugation of methoxypolyethylene glycol to the surface of bovine red blood cells Biotechnol Bioeng 96 1199 1210 1:CAS:528:DC%2BD2sXkt1CgtL4%3D 10.1002/bit.21204 17009332 (Pubitemid 46648678)
6. AM Chen MD Scott 2003 Immunocamouflage: prevention of transfusion-induced graft-versus-host disease via polymer grafting of donor cells J Biomed Mater Res A 67 626 636 10.1002/jbm.a.10146 14566806
7. K Hochweller CH Sweenie SM Anderton 2006 Circumventing tolerance at the T cell or the antigen-presenting cell surface: antibodies that ligate CD40 and OX40 have different effects Eur J Immunol 36 389 396 1:CAS:528: DC%2BD28XhvFWmsr0%3D 10.1002/eji.200535506 16402409 (Pubitemid 43257462)
8. G Wang Y Feng J Hao A Li X Gao S Xie 2005 Induction of xenogeneic islet transplantation tolerance by simultaneously blocking CD28-B7 and OX40-OX40L co-stimulatory pathways Sci China C Life Sci 48 515 522 1:CAS:528: DC%2BD2MXht12qtL7I 10.1360/062004-127 16315603 (Pubitemid 44804715)
9. T Iwasaki 2004 Recent advances in the treatment of graft-versus-host disease Clin Med Res 2 243 252 1:CAS:528:DC%2BD2cXhtFCht7bJ 10.3121/cmr.2.4.243 15931364
10. MY Kim V Bekiaris FM McConnell FM Gaspal C Raykundalia PJ Lane 2005 OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors J Immunol 174 1433 1437 1:CAS:528:DC%2BD2MXlsFynsQ%3D%3D 15661901
11. KR Cooke L Kobzik TR Martin J Brewer J Delmonte Jr JM Crawford, et al. 1996 An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin Blood 88 3230 3239 1:CAS:528:DyaK28XmtlWju7w%3D 8963063
12. O Asai DL Longo ZG Tian RL Hornung DD Taub FW Ruscetti, et al. 1998 Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation J Clin Invest 101 1835 1842 1:CAS:528:DyaK1cXjt1SrsbY%3D 10.1172/JCI1268 9576746
13. K Sun DE Wilkins MR Anver TJ Sayers A Panoskaltsis-Mortari BR Blazar, et al. 2005 Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity Blood 106 3293 3299 1:CAS:528:DC%2BD2MXht1WntrvP 10.1182/blood-2004-11-4526 15961519 (Pubitemid 41565932)
14. G Yang SQ Tang JW Wang Y Liu LZ Liu C Feng 2007 Ex vivo chemical modification of graft cells by methoxy polyethylene glycol alleviates graft versus host disease after haploidentical stem cell transplantation in mice Zhongguo Shi Yan Xue Ye Xue Za Zhi 15 1240 1242 1:CAS:528:DC%2BD1MXovFGksw%3D%3D 18088475
15. Y Sun I Tawara T Toubai P Reddy 2007 Pathophysiology of acute graft-versus-host disease: recent advances Transl Res 150 197 214 1:CAS:528:DC%2BD2sXhtFWhtr%2FE 10.1016/j.trsl.2007.06.003 17900507 (Pubitemid 47444613)
16. P Reddy JL Ferrara 2003 Immunobiology of acute graft-versus-host disease Blood Rev 17 187 194 10.1016/S0268-960X(03)00009-2 14556773 (Pubitemid 37356389)
17. M Oshima MZ Atassi 2000 T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses Autoimmunity 32 45 55 1:CAS:528: DC%2BD3cXot1Onu7g%3D 10.3109/08916930008995987 10958175
18. RM Maizels M Yazdanbakhsh 2003 Immune regulation by helminth parasites: cellular and molecular mechanisms Nat Rev Immunol 3 733 744 1:CAS:528: DC%2BD3sXmvVWmtbw%3D 10.1038/nri1183 12949497 (Pubitemid 41070814)
19. L Serghides J Bukczynski T Wen C Wang JP Routy MR Boulassel, et al. 2005 Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL J Immunol 175 6368 6377 1:CAS:528:DC%2BD2MXhtF2jurzP 16272289
20. PA Taylor A Panoskaltsis-Mortari GJ Freeman AH Sharpe RJ Noelle AY Rudensky, et al. 2005 Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM) Blood 105 3372 3380 1:CAS:528:DC%2BD2MXjtlSls7g%3D 10.1182/blood-2004-10-3869 15618467
21. I Mendel EM Shevach 2006 Activated T cells express the OX40 ligand: requirements for induction and costimulatory function Immunology 117 196 204 1:CAS:528:DC%2BD28Xit1Siurc%3D 10.1111/j.1365-2567.2005.02279.x 16423055
22. BR Blazar AH Sharpe AI Chen A Panoskaltsis-Mortari C Lees H Akiba, et al. 2003 Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients Blood 101 3741 3748 1:CAS:528:DC%2BD3sXjs1aqtLo%3D 10.1182/blood-2002-10-3048 12521997 (Pubitemid 36857967)
23. N Tsukada H Akiba T Kobata Y Aizawa H Yagita K Okumura 2000 Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation Blood 95 2434 2439 1:CAS:528:DC%2BD3cXitFeitLc%3D 10733518
24. M Edinger P Hoffmann J Ermann K Drago CG Fathman S Strober, et al. 2003 CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation Nat Med 9 1144 1150 1:CAS:528:DC%2BD3sXmvVWnsrs%3D 10.1038/nm915 12925844 (Pubitemid 37173698)
25. DH Fowler 2006 Shared biology of GVHD and GVT effects: potential methods of separation Crit Rev Oncol Hematol 57 225 244 10.1016/j.critrevonc.2005.07.001 16207532 (Pubitemid 43238327)
26. L Ruggeri A Mancusi E Burchielli F Aversa MF Martelli A Velardi 2006 Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation Cytotherapy 8 554 558 1:CAS:528:DC%2BD2sXit1aqur4%3D 10.1080/14653240601078721 17148031 (Pubitemid 44869855)
27. M Remberger M Jaksch M Uzunel J Mattsson 2003 Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation Eur J Haematol 70 384 391 1:CAS:528:DC%2BD3sXltlGqt7Y%3D 10.1034/j.1600-0609.2003.00078.x 12756021 (Pubitemid 36713934)